(CBT) Cabot - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270551013
CBT: Rubber, Carbon, Silica, Alumina, Aerogel, Masterbatch, Inkjet
Cabot Corporation (NYSE:CBT) is a specialty chemicals and performance materials company with a diverse portfolio of products that play a critical role in various industries. Operating through two main segments—Reinforcement Materials and Performance Chemicals—the company has established itself as a key supplier of advanced materials that enhance the performance of everyday products.
The Reinforcement Materials segment focuses on carbon black, a reinforcing agent used primarily in tires and industrial rubber products. This segment also produces engineered elastomer composites, which are used in automotive and industrial applications. Carbon black is essential for improving the durability and traction of tires, making it a cornerstone product for the automotive industry.
The Performance Chemicals segment is equally significant, offering a range of specialty chemicals that are used in a variety of applications. This includes fumed silica and fumed alumina, which are used in adhesives, sealants, cosmetics, and batteries. The company also produces conductive additives for lead acid and lithium-ion batteries, which are critical for the growing electric vehicle market. Additionally, Cabot provides inkjet colorants for digital printing and aerogel, a lightweight, high-performance insulation material used in construction and industrial applications.
Cabots products are sold globally through a network of distributors and sales representatives, with operations spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific. This global reach ensures that the company is well-positioned to serve a wide range of industries, including automotive, electronics, construction, and consumer goods.
Founded in 1882 and headquartered in Boston, Massachusetts, Cabot Corporation has a long history of innovation and has evolved to meet the changing needs of its customers. With a market capitalization of approximately $4.76 billion and a forward P/E ratio of 11.48, the company offers investors exposure to the specialty chemicals sector with a focus on sustainability and performance.
From tires and batteries to cosmetics and electronics, Cabots materials are integral to modern manufacturing. Their ability to innovate and adapt to emerging trends makes them a key player in the specialty chemicals industry.
Additional Sources for CBT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CBT Stock Overview
Market Cap in USD | 4,602m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 1980-11-05 |
CBT Stock Ratings
Growth 5y | 73.6% |
Fundamental | 48.7% |
Dividend | 61.4% |
Rel. Strength Industry | 0.69 |
Analysts | 3.6/5 |
Fair Price Momentum | 83.87 USD |
Fair Price DCF | 190.49 USD |
CBT Dividends
Dividend Yield 12m | 1.94% |
Yield on Cost 5y | 7.39% |
Annual Growth 5y | 3.84% |
Payout Consistency | 92.6% |
CBT Growth Ratios
Growth Correlation 3m | -90.4% |
Growth Correlation 12m | -7.5% |
Growth Correlation 5y | 94.9% |
CAGR 5y | 28.50% |
CAGR/Max DD 5y | 0.95 |
Sharpe Ratio 12m | -0.56 |
Alpha | -13.47 |
Beta | 1.15 |
Volatility | 45.19% |
Current Volume | 314.3k |
Average Volume 20d | 493.5k |
As of March 14, 2025, the stock is trading at USD 81.62 with a total of 314,345 shares traded.
Over the past week, the price has changed by -2.91%, over one month by -4.45%, over three months by -20.65% and over the past year by -4.64%.
Partly, yes. Based on ValueRay Fundamental Analyses, Cabot (NYSE:CBT) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.71 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CBT as of March 2025 is 83.87. This means that CBT is currently overvalued and has a potential downside of 2.76%.
Cabot has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CBT.
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CBT Cabot will be worth about 93.6 in March 2026. The stock is currently trading at 81.62. This means that the stock has a potential upside of +14.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 101 | 23.7% |
Analysts Target Price | 111 | 36% |
ValueRay Target Price | 93.6 | 14.7% |